menu
    • menu
    [{"orgOrder":0,"company":"Bioiberica","sponsor":"Artialis","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SPAIN","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Chondroitin Sulfate Sodium","moa":"||Undisclosed","graph1":"Musculoskeletal","graph2":"Phase IV","graph3":"Bioiberica","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bioiberica \/ Artialis","highestDevelopmentStatusID":"11","companyTruncated":"Bioiberica \/ Artialis"},{"orgOrder":0,"company":"Bioiberica","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"SPAIN","productType":"Dietary Supplement","year":"2016","type":"Inapplicable","leadProduct":"Chondroitin Sulfate Sodium","moa":"||Undisclosed","graph1":"Musculoskeletal","graph2":"Phase IV","graph3":"Bioiberica","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bioiberica \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Bioiberica \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals for Artrox (TN)

    Menu

    Artrox (TN)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Bioiberica

                            Spain
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

                            Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine Hydrochloride

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Primary Care Study With Chondroitin Sulfate and Glucosamine Hydrochloride in Hand Osteoarhritis

                            Details : Droglican is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Osteoarthritis, Hand.

                            Product Name : Droglican

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 06, 2016

                            Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine Hydrochloride

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase IV

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Bioiberica Company Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Bioiberica

                            Spain
                            BIO Partnering at JPM
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothBioiberica is a global life science company committed to improving the health & wellbeing of people, animals & plants.

                            Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine Hydrochloride

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase IV

                            Sponsor : Artialis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of the Evolution of Imaging Markers of Cartilage Degradation in Patients With Knee Osteoarthritis R...

                            Details : Droglican is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Droglican

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            July 01, 2016

                            Lead Product(s) : Chondroitin Sulfate Sodium,Glucosamine Hydrochloride

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase IV

                            Sponsor : Artialis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            Bioiberica Company Banner

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.